National Vision Holdings ROE 2015-2019 | EYE

Current and historical return on equity (ROE) values for National Vision Holdings (EYE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. National Vision Holdings ROE for the three months ending March 31, 2019 was 6.29%.
National Vision Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $0.02B $0.76B 2.14%
2018-12-31 $0.02B $0.74B 3.13%
2018-09-30 $0.07B $0.76B 9.67%
2018-06-30 $0.07B $0.73B 11.06%
2018-03-31 $0.05B $0.71B 12.58%
2017-12-31 $0.04B $0.66B 19.34%
2017-09-30 $0.02B $0.26B 28.24%
2017-06-30 $0.02B $0.00B inf%
2017-03-31 $0.02B $0.00B 20.73%
2016-12-31 $0.00B $0.00B 3.11%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.421B $1.537B
National Vision Holdings, Inc. is involved in optical retail primarily in the United States. The company offer product and services for eye care needs through retail stores and consumer websites. Its brand portfolio consists of America's Best Contacts & Eyeglasses, Eyeglass World, Vision Centers inside select Walmart stores and Vista Optical locations inside Fred Meyer stores and on select military bases. National Vision Holdings, Inc. is headquartered in Duluth, Georgia.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.773B 28.88
Medtronic (MDT) Ireland $132.439B 18.92
Stryker (SYK) United States $74.804B 26.70
Boston Scientific (BSX) United States $57.935B 27.77
Baxter (BAX) United States $41.482B 26.15
Zimmer Biomet Holdings (ZBH) United States $24.447B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $19.056B 0.00
ResMed (RMD) United States $17.285B 33.03
Canopy Growth (CGC) Canada $14.734B 0.00
Bio-Rad Laboratories (BIO) United States $9.176B 48.65
Aurora Cannabis (ACB) Canada $7.585B 74.80
Insulet (PODD) United States $7.205B 524.91
Hill-Rom Holdings (HRC) United States $7.115B 21.57
Perrigo (PRGO) Ireland $6.034B 10.20
Haemonetics (HAE) United States $6.002B 48.99
GW Pharmaceuticals (GWPH) United Kingdom $5.303B 0.00
ICU Medical (ICUI) United States $5.078B 30.30
Hutchison China MediTech (HCM) China $3.822B 0.00
Neogen (NEOG) United States $3.283B 53.38
NuVasive (NUVA) United States $3.047B 24.89
Agios Pharmaceuticals (AGIO) United States $3.019B 0.00
Quidel (QDEL) United States $2.341B 24.30
Aphria (APHA) $1.690B 0.00
Cardiovascular Systems (CSII) United States $1.513B 869.00
HEXO (HEXO) $1.479B 0.00
Phibro Animal Health (PAHC) United States $1.209B 18.11
AtriCure (ATRC) United States $1.181B 0.00
VAREX IMAGING (VREX) United States $1.121B 23.79
Lantheus Holdings (LNTH) United States $1.092B 29.01
OrganiGram Holdings (OGI) Canada $0.973B 0.00
NanoString Technologies (NSTG) United States $0.945B 0.00
PetIQ (PETQ) United States $0.927B 22.51
Quanterix (QTRX) United States $0.859B 0.00
MacroGenics (MGNX) United States $0.817B 0.00
Omeros (OMER) United States $0.816B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.753B 21.12
Cerus (CERS) United States $0.678B 0.00
TG Therapeutics (TGTX) United States $0.676B 0.00
Surmodics (SRDX) United States $0.585B 85.04
OraSure Technologies (OSUR) United States $0.549B 25.26
LeMaitre Vascular (LMAT) United States $0.536B 25.93
Meridian Bioscience (VIVO) United States $0.499B 15.26
Evolus (EOLS) United States $0.374B 0.00
Vapotherm (VAPO) United States $0.363B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.359B 0.00
Zynex (ZYXI) United States $0.335B 34.60
BioLife Solutions (BLFS) United States $0.331B 103.53
Utah Medical Products (UTMD) United States $0.328B 22.71
Bovie Medical (APYX) United States $0.226B 0.00
Cytosorbents (CTSO) United States $0.212B 0.00
Owens & Minor (OMI) United States $0.184B 3.91
Rockwell Medical (RMTI) United States $0.180B 0.00
Chimerix (CMRX) United States $0.169B 0.00
Fonar (FONR) United States $0.135B 7.11
Female Health (VERU) United States $0.131B 0.00
Chembio Diagnostics (CEMI) United States $0.105B 0.00
BRAINSWAY LTD (BWAY) Israel $0.102B 0.00
Neurotrope (NTRP) United States $0.091B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
United-Guardian (UG) United States $0.088B 19.35
Surface Oncology (SURF) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Trinity Biotech (TRIB) Ireland $0.039B 13.67
Senestech (SNES) United States $0.035B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.033B 0.00
GUARDION HEALTH (GHSI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.016B 0.00
Myomo (MYO) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.93